Citation Impact
Citing Papers
Analysis of T Cell Responses during Active Varicella-Zoster Virus Reactivation in Human Ganglia
2013
Cell entry mechanisms of SARS-CoV-2
2020 Standout
Characterization of the Host Immune Response in Human Ganglia after Herpes Zoster
2010
Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2
2020 StandoutScience
Role of viruses in etiology and pathogenesis of multiple sclerosis
2001
The B cell response in multiple sclerosis
2006
Comparative Biology of Latent Varicella-Zoster Virus and Herpes Simplex VirusInfections
1992
Neurologic Complications of the Reactivation of Varicella–Zoster Virus
2000 Standout
Clonal expansion and somatic hypermutation of V(H) genes of B cells from cerebrospinal fluid in multiple sclerosis.
1998
Another case of virologically confirmed zoster sine herpete, with electrophysiologic correlation
1996
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
2020 Standout
Varicella Zoster Viral Disease
1999
Profound cerebrospinal fluid pleocytosis and Froin's Syndrome secondary to widespread necrotizing vasculitis in an HIV-positive patient with varicella zoster virus encephalomyelitis
1998
Postherpetic Neuralgia — Pathogenesis, Treatment, and Prevention
1996 Standout
Rheumatoid arthritis
2016 Standout
Mechanisms Underlying Inflammation in Neurodegeneration
2010 Standout
Therapeutic Approaches to Varicella-Zoster Virus Infections
1992
B cells and antibodies in CNS demyelinating disease
2001
Diagnosis and Therapy of Herpes Zoster Ophthalmicus
1991
Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus
2003 StandoutNature
Increased synthetic peptide specificity of tissue-CSF bound anti-MBP in multiple sclerosis
1993
The dynamic disulphide relay of quiescin sulphydryl oxidase
2012 StandoutNatureNobel
Guillain–Barré Syndrome
2012 Standout
The patterns of varicella zoster virus encephalitis
1996
Localization of herpes simplex virus and varicella zoster virus DNA in human ganglia
1992
Phage-encoded combinatorial chemical libraries based on bicyclic peptides
2009 StandoutNobel
Nitric Oxide and Peroxynitrite in Health and Disease
2007 Standout
B-Cell Depletion with Rituximab in Relapsing–Remitting Multiple Sclerosis
2008 Standout
Matching of oligoclonal immunoglobulin transcriptomes and proteomes of cerebrospinal fluid in multiple sclerosis
2008
Multiple sclerosis
2008 Standout
Immune Response of Elderly Individuals to a Live Attenuated Varicella Vaccine
1992
Varicella zoster virus, a cause of waxing and waning vasculitis
1996
An in vivo model of varicella‐zoster virus latent infection of dorsal root ganglia
1990
Efficacy of an Adjuvanted Herpes Zoster Subunit Vaccine in Older Adults
2015 Standout
Serum autoantibodies to cell surface determinants in multiple sclerosis: a flow cytometric study
2004
Unilateral postherpetic neuralgia is associated with bilateral sensory neuron damage
1998
Detection of varicella‐zoster virus DNA in blood of children with varicella
1994
Broad-Spectrum Antibiotic or G-CSF as Potential Countermeasures for Impaired Control of Bacterial Infection Associated with an SPE Exposure during Spaceflight
2015 StandoutNobel
Systemic Lupus Erythematosus
2011 Standout
Persistence of varicalla-zoster virus DNA in elderly patients with postherpetic neuralgia
1995
Oligoclonal expansion of memory CD8+ T cells in cerebrospinal fluid from multiple sclerosis patients
2002
Angiotensin-converting enzyme 2 protects from severe acute lung failure
2005 StandoutNature
Hindlimb Suspension and SPE-Like Radiation Impairs Clearance of Bacterial Infections
2014 StandoutNobel
IMMUNE RESPONSES TO VARICELLA-ZOSTER VIRUS
1996
Structure of the Ultra-High-Affinity Colicin E2 DNase–Im2 Complex
2012 StandoutNobel
Detection of Varicella-Zoster Virus DNA in Human Geniculate Ganglia by Polymerase Chain Reaction
1992
Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein
2020 Standout
Stress‐induced subclinical reactivation of varicella zoster virus in astronauts
2003
Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC
2013 StandoutNature
Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria
2011 Standout
Detection of latent varicella zoster virus DNA and human gene sequences in human trigeminal ganglia by in situ amplification combined with in situ hybridization
1995
Directed Evolution of Protein Inhibitors of DNA-nucleases by in Vitro Compartmentalization (IVC) and Nano-droplet Delivery
2004
Restricted Transcription of Varicella-Zoster Virus in Latently Infected Human Trigeminal and Thoracic Ganglia
1992
Clonal expansion of IgA-positive plasma cells and axon-reactive antibodies in MS lesions
2005
Investigation of varicella‐zoster virus DNA by the polymerase chain reaction in healthy children with varicella vaccination
1994
Structural and Functional Basis of SARS-CoV-2 Entry by Using Human ACE2
2020 Standout
The Neurobiology of Multiple Sclerosis: Genes, Inflammation, and Neurodegeneration
2006
Zoster myelitis
1996
Exploring protein fitness landscapes by directed evolution
2009 StandoutNobel
PREVENTION OF HERPES ZOSTER
1996
Latent Varicella–Zoster Viral DNA in Human Trigeminal and Thoracic Ganglia
1990
Recent Advances in Varicella-Zoster Virus Infection
1999
Herpes Zoster
2013 Standout
Increased Risk of Guillain‐Barré Syndrome following Recent Herpes Zoster: A Population‐Based Study across Taiwan
2010
Experimental and Computational Analyses of the Energetic Basis for Dual Recognition of Immunity Proteins by Colicin Endonucleases
2008 StandoutNobel
The virology of demyelinating diseases
1994
Inhibition of SARS-CoV-2 Infections in Engineered Human Tissues Using Clinical-Grade Soluble Human ACE2
2020 Standout
Herpes Zoster
2002 Standout
Biomarkers in multiple sclerosis
2015
Neuropathic pain: aetiology, symptoms, mechanisms, and management
1999 Standout
Structural basis of receptor recognition by SARS-CoV-2
2020 StandoutNature
Pain and its persistence in herpes zoster
1996
B lineage cells in the inflammatory central nervous system environment: Migration, maintenance, local antibody production, and therapeutic modulation
2006
Varicella-Zoster Virus-Specific Immunity after Herpes Zoster
1991
Varicella-zoster virus gene 63 encodes an immediate-early protein that is abundantly expressed during latency
1995
Varicella-zoster virus (VZV) transcription during latency in human ganglia: prevalence of VZV gene 21 transcripts in latently infected human ganglia
1995
Isoelectric focusing of IgG eluted from multiple sclerosis and subacute sclerosing panencephalitis brains
1980 Nature
The structural and energetic basis for high selectivity in a high-affinity protein-protein interaction
2010 StandoutNobel
Varicella zoster virus-associated focal vasculitis without herpes zoster: Recovery after treatment with acyclovir
1998
Varicella-Zoster Virus Infection of Strain 2 Guinea Pigs
1985
Signaling Recognition Events with Fluorescent Sensors and Switches
1997 Standout
Patterns of gene expression and sites of latency in human nerve ganglia are different for varicella-zoster and herpes simplex viruses.
1988
The Complete DNA Sequence of Varicella-Zoster Virus
1986 Standout
Analysis of the Plasma Peptidome from Pancreas Cancer Patients Connects a Peptide in Plasma to Overexpression of the Parent Protein in Tumors
2009
Intrathecal Interferon Reduces Exacerbations of Multiple Sclerosis
1981 Science
Reactivated and latent varicella-zoster virus in human dorsal root ganglia.
1995
Structure of SARS Coronavirus Spike Receptor-Binding Domain Complexed with Receptor
2005 StandoutScience
Angiotensin-Converting Enzyme II in the Heart and the Kidney
2006
Quantitation of Varicella-Zoster Virus DNA in Whole Blood, Plasma, and Serum by PCR and Electrochemiluminescence
2000
Multiple Sclerosis
2018 Standout
Prevalence of Varicella-Zoster Virus DNA in Dissociated Human Trigeminal Ganglion Neurons and Nonneuronal Cells
1999
Varicella-zoster virus
1996 Standout
The role of B cells and autoantibodies in multiple sclerosis
2000
Physical maps of varicella-zoster virus DNA derived with 11 restriction enzymes
1984
Retroviruses Pseudotyped with the Severe Acute Respiratory Syndrome Coronavirus Spike Protein Efficiently Infect Cells Expressing Angiotensin-Converting Enzyme 2
2004
IMMUNOLOGY OF MULTIPLE SCLEROSIS
2005 Standout
Varicella-zoster virus (VZV) transcription during latency in human ganglia: detection of transcripts mapping to genes 21, 29, 62, and 63 in a cDNA library enriched for VZV RNA
1996
Acute herpetic and postherpetic neuralgia: Clinical review and current management
1986
Electrochemiluminescence (ECL)
2004 Standout
Recapitulation of B cell differentiation in the central nervous system of patients with multiple sclerosis
2004
How neuroinflammation contributes to neurodegeneration
2016 StandoutScience
De novo design of covalently constrained mesosize protein scaffolds with unique tertiary structures
2017 StandoutNobel
Luminescent Labels—More than Just an Alternative to Radioisotopes?
1994
Zoster sine herpete, A clinical variant
1994
Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation
2020 StandoutScience
Accumulation of Clonally Related B Lymphocytes in the Cerebrospinal Fluid of Multiple Sclerosis Patients
2000
Analyses of cerebrospinal fluid in the diagnosis and monitoring of multiple sclerosis
2009
Rapid Evolution of RNA Genomes
1982 StandoutScience
B Cell Repertoire Diversity and Clonal Expansion in Multiple Sclerosis Brain Lesions
1999
Antibodies from Inflamed Central Nervous System Tissue Recognize Myelin Oligodendrocyte Glycoprotein
2005
Herpes zoster ophthalmicus and delayed contralateral hemiparesis caused by cerebral angiitis: Diagnosis and management approaches
1983
Precision glycocalyx editing as a strategy for cancer immunotherapy
2016 StandoutNobel
Configuration of latent varicella-zoster virus DNA
1995
Prevention of herpes zoster: recommendations of the Advisory Committee on Immunization Practices (ACIP).
2008 Standout
Progressive encephalitis three months after resolution of cutaneous zoster a patient with AIDS
1986
Expression of protein encoded by varicella-zoster virus open reading frame 63 in latently infected human ganglionic neurons.
1996
Electrogenerated Chemiluminescence and Its Biorelated Applications
2008 Standout
Varicella-zoster virus-specific cytotoxic T lymphocytes (Tc): detection and frequency analysis of HLA class I-restricted Tc in human peripheral blood
1987
Aberrant intracellular localization of Varicella-Zoster virus regulatory proteins during latency
1998
The glycoprotein products of varicella-zoster virus gene 14 and their defective accumulation in a vaccine strain (Oka)
1990
New common nomenclature for glycoprotein genes of varicella-zoster virus and their glycosylated products
1986
Therapeutic antibodies: their mechanisms of action and the pathological findings they induce in toxicity studies
2015
Quantitation of latent varicella-zoster virus DNA in human trigeminal ganglia by polymerase chain reaction
1993
Cytokine production in varicella zoster virus-stimulated limiting dilution lymphocyte cultures
1994
Expression of varicella-zoster virus in blood mononuclear cells of patients with postherpetic neuralgia.
1988
Latent varicella–zoster virus is located predominantly in neurons in human trigeminal ganglia
1998
Detection of varicella‐zoster virus in lymphocytes by DNA hybridization
1987
Increased incidence of herpes zoster in normal children infected with varicella zoster virus during infancy: Community-based follow-up study
1986
Stapled β-Hairpins Featuring 4-Mercaptoproline
2021 StandoutNobel
Isolation of virus from brain after immunosuppression of mice with latent herpes simplex
1981 StandoutNatureNobel
Inversion and circularization of the varicella-zoster virus genome
1985
DNA sequence of the US component of the varicella-zoster virus genome.
1983
Comparison of immunoglobulin G heavy-chain sequences in MS and SSPE brains reveals an antigen-driven response
2000
Comparison of biotinylated DNA and RNA probes for rapid detection of varicella-zoster virus genome by in situ hybridization
1991
Human lupus autoantibodies against NMDA receptors mediate cognitive impairment
2006
Works of Mary Devlin being referenced
Detection of varicella‐zoster virus nucleic acid in neurons of normal human thoracic ganglia
1987
Varicella-Zoster Virus Reactivation without Rash
1992
Extraction and purification of active IgG from SSPE and MS brain
1997
Restricted use of VH4 Germline segments in an acute multiple sclerosis brain
1998
Novel Peptide Inhibitors of Angiotensin-converting Enzyme 2
2003
Persistence of varicella-zoster virus DNA in blood mononuclear cells of patients with varicella or zoster
1989
Fatal varicella‐zoster virus meningoradiculitis without skin involvement
1991
Peripheral Blood Mononuclear Cells of the Elderly Contain Varicella-Zoster Virus DNA
1992
Development of Mammalian Serum Albumin Affinity Purification Media by Peptide Phage Display
2002
Rapid generation of functional human IgG antibodies derived from Fab-on-phage display libraries
2004
Cytomegalovirus Isolation from a Chimpanzee with Acute Demyelinating Disease After Inoculation of Multiple Sclerosis Brain Cells
1979
The production of varicella zoster virus antiserum in laboratory animals
1982
Varicella-zoster virus (VZV) transcription during latency in human ganglia: construction of a cDNA library from latently infected human trigeminal ganglia and detection of a VZV transcript
1994
The Internal Organization of the Varicella-Zoster Virus Genome
1982
Extraction of cell-associated varicella-zoster virus DNA with Triton X-100-NaCl
1982
Varicella-zoster virus DNA in human sensory ganglia
1983 Nature
ISOLATION OF HERPES SIMPLEX VIRUS FROM HUMAN TRIGEMINAL GANGLIA, INCLUDING GANGLIA FROM ONE PATIENT WITH MULTIPLE SCLEROSIS
1977
Expression of varicella-zoster virus and herpes simplex virus in normal human trigeminal ganglia.
1988
Acute simian varicella infection. Clinical, laboratory, pathologic, and virologic features.
1992
A technique for the elution of cell‐surface antibody from human brain tissue
1978
Affinity-purified Varicella-Zoster Virus Glycoprotein gp1/gp3 Stimulates the Production of Neutralizing Antibody
1985